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Abstract
The neurohormone oxytocin (OT) has been one the most studied peptides in
behavioral sciences over the past two decades. Primarily known for its crucial role
in labor and lactation, a rapidly growing literature suggests that intranasal OT (IN-
OT) may also play a role in humans’ emotional and social lives. However, the lack
of a convincing theoretical framework explaining IN-OT’s effects that would also
allow to predict which moderators exert their effects and when, has raised healthy
skepticism regarding the robustness of human behavioral IN-OT research. The
poor knowledge of OT’s exact pharmacokinetic properties, crucial statistical and
methodological issues and the absence of direct replication efforts may have
lead to a publication bias in IN-OT literature with many unpublished studies with
null results lying in laboratories’ drawers. Is there a file drawer problem in IN-OT
research? If this is the case, it must also be the case in our laboratory. This paper
aims to answer ...
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The neurohormone oxytocin (OT) has been one the most studied peptides in behavioural sciences
over the past two decades. Primarily known for its crucial role in labour and lactation, a rapidly
growing literature suggests that intranasal OT (IN-OT) may also play a role in the emotional and
social lives of humans. However, the lack of a convincing theoretical framework explaining the
effects of IN-OT that would also allow the prediction of which moderators exert their effects
and when has raised healthy skepticism regarding the robustness of human behavioural IN-OT
research. Poor knowledge of the exact pharmacokinetic properties of OT, as well as crucial sta-
tistical and methodological issues and the absence of direct replication efforts, may have lead
to a publication bias in the IN-OT literature, with many unpublished studies with null results
remaining buried in laboratory drawers. Is there a file drawer problem in IN-OT research? If this
is the case, it may also be true in our own laboratory. The present study aims to answer this
question, document the extent of the problem and discuss its implications for OT research. For
eight studies (including 13 dependent variables overall, as assessed through 25 different para-
digms) performed in our laboratory between 2009 and 2014 on 453 subjects, the results
obtained were too often not those that were expected. Only five publications emerged from our
studies and only one of these reported a null finding. After realising that our publication portfo-
lio has become less and less representative of our actual findings and because the nonpublica-
tion of our data might contribute to generating a publication bias in IN-OT research, we decided
to retrieve these studies from our drawer and encourage other laboratories to do the same.
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Behavioural scientists have been investigating the psychosocial
effects of the neuropeptide oxytocin (OT) in humans for over
two decades, making it one of the most studied hormones in
the social sciences. A rapidly growing literature suggests that OT,
which has a well-established physiological role in labour and lac-
tation, may also play a role in the emotional and social lives of
humans.
During the past two decades, preliminary findings have sug-
gested that intranasal OT (IN-OT) administration increases trust
toward strangers (1,2), promotes self-confidence (3,4), improves
recognition of familiar faces (5), enhances emotional recognition (6)
and facilitates mind reading (7). Other studies proposed that IN-OT
also fosters sharing of emotions with others (8), makes people more
sensitive to the feelings of others (9), promotes altruism (10),
enhances perceived trustworthiness and attractiveness and
facilitates parent–infant (11) and romantic (12) attachments. These
findings helped to build the reputation of OT as the prosocial hor-
mone par excellence, and the popular press has largely reinforced
this reputation.
Nevertheless, several findings have tempered this idealistic view
of IN-OT. For example, it has been proposed that IN-OT might also
promote antisocial behaviour, such as aggression (13), ethnocen-
trism (14) and gloating (15). These findings have questioned the
mainstream theory of IN-OT as an affiliative/prosocial hormone (16)
and motivated the proposal of several new hypotheses. Two of
them in particular have been studied in depth: the first postulates
that IN-OT increases the salience of social cues (16) and the second
conjectures that IN-OT increases social approach behaviours,
whether good or bad (17). Studies to date have not clearly favoured
one theory over the others. Some findings have been consistent
with one (or more) of these theories, although others do not sit
easily with either (18).
Another proposition that has emerged from the behavioural IN-OT
literature is that the influences of IN-OT are strongly moderated by
environmental context and personal characteristics. A recent review
(19) has concluded that the majority of IN-OT studies do not yield a
main IN-OT treatment effects. To account for such findings, it was
proposed that the effect of IN-OT might occur only under certain cir-
cumstances or only as a function of specific personality traits, reflect-
ing the plausible complexity of the interaction between IN-OT,
environment and genotype. The lack of a convincing theoretical
framework that allows to predict which moderators would exert their
effects and when has raised healthy skepticism regarding the robust-
ness of human behavioural IN-OT research (20,21).
One source of skepticism is that the vast IN-OT research enter-
prise has relied on the pharmacokinetic properties of arginine vaso-
pressin administration, a peptide that is structurally similar, yet not
identical to OT (22–24). IN-OT pharmacokinetics are not fully under-
stood and the only study conducted to date (with a very small
sample size) found that IN-OT does not yield elevated cerebrospinal
fluid (CSF) OT levels 45 min after administration (the time window
following administration at which most behavioural tasks took
place) (25). Moreover, it is uncertain whether the standard doses
used in OT research (between 24 and 40 IU) can deliver sufficient
quantities of OT to the brain to produce significant changes in indi-
viduals, especially because OT is avidly degraded in brain tissue
(24). Future studies investigating the penetration of IN-OT into
brain and its pharmacokinetic properties in human are crucially
needed.
A second source of skepticism concerns statistics. A recent meta-
analysis of published studies involving IN-OT in humans (21) demon-
strated that most studies are dramatically underpowered [e.g. the
results of Walum et al. (21) indicate that the average study investi-
gating intranasal OT in healthy subjects has a statistical power of
16%] and report overestimated effects. The meta-analysts estimated
(using information on power, pre-study odds and the a level) that the
false discovery rate in the IN-OT literature is over 80%.
A third source of skepticism is a striking absence of efforts
towards direct replication. As far as we know, almost none of the
findings in the literature underwent direct replication attempts,
despite the obvious importance of such efforts (26). Moreover, the
seminal, highly cited study associating IN-OT with trust (1), which
inspired much of the subsequent research, failed to replicate several
times (20). Our laboratory has also failed to replicate a promising
initial finding relating IN-OT to increased trust in a non-monetary
behavioural task [for the original study, see Mikolajczak et al. (2);
for the failed replication, see Lane et al. (27)]. Furthermore, a recent
study failed to replicate seminal findings associating IN-OT with
mind-reading [for the original study, see Domes et al. (7); for the
failed replication, see Radke and de Bruijn (28)].
Finally, the methodological challenges accompanying behavioural
OT research are not unique to the use of IN-OT administration: the
literature using peripheral OT measurements also relies on OT assay
methods that are considered by many researchers as bio-analyti-
cally invalid (29–31).
In the light of these concerns and after failing to replicate
our own IN-OT trust-enhancing effect (2), we proposed four,
non-mutually exclusive, hypotheses regarding the true association
between IN-OT and social behaviour (27):
• The effects reported in the literature reflect the true state of
the world, and failed replications are a result of underpowered
studies or methodological errors/differences.
• The effects found in the literature are indicative of an effect of
IN-OT in humans, whereas the true effect of IN-OT on human
behaviour is much smaller than the impression given by pub-
lished studies. Replications and highly powered studies would
therefore allow adjustment of the real effect size.
• The effects found in the literature are type I errors that reflect
a publication bias of positive results (32), which is possible
because a rate of type I error of 5% is generally accepted.
• The effects of IN-OT do not truly exist but are artificially cre-
ated (e.g. by extensive degree of researcher freedom (33) and
study misconduct, etc.).
If either of the two last hypotheses is true, many unpublished
studies with null results might have remained buried in laboratory’s
drawers (32).
Is there a file drawer problem in IN-OT research? If this is the case,
it might also be the case in our own laboratory. This present study
aimed to answer that question, document the extent of the problem
and discuss its implications for IN-OT research. We present eight
studies (including 13 dependent variables overall, as assessed through
25 different paradigms) that were performed in our laboratory from
2009 until 2014 on a total of 453 subjects. All our studies relied on
the theoretical and experimental accounts of the role of IN-OT in
social behaviour that had been published to date. As we demonstrate
below, the results obtained were too often not those that were
expected. Only four studies (most often a part of them) of the eight
were submitted for publication, yielding five articles (2,8,27,34,35). Of
these five article, only one (27) reported a null finding. We submitted
several studies yielding null findings to different journals (from those
with a general interest in psychology to those specialised in biological
psychology and in psychoenodcrinolgy), although they were rejected
time and time again [we submitted four articles that were rejected at
least once (IN-OT and conformity to peer pressure, submitted once
and rejected after review; IN-OT and mimetic desire, submitted twice
and rejected twice after review; IN-OT and compassion, submitted
twice and rejected twice after review; failed replication of IN-OT
effect on trust, submitted twice, rejected once after review and then
accepted in another journal)]. After realising that our publication
portfolio has become less and less representative of our actual find-
ings, and because the nonpublication of our null findings might con-
tribute to generating a publication bias in IN-OT research, we decided
to retrieve these studies out of our drawer, hoping that other labora-
tories will do the same.
To avoid an overly pessimistic view by only presenting the null
results obtained, we instead present a complete overview of the
research performed in our laboratory since we started studying IN-
OT in 2009. This will allow readers to form their own opinion about
the findings and allow us to meta-analyse the cumulative effects.
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Methods and Results
Methods
We present eight studies assessing 13 dependent variables (emotional, cog-
nitive, behavioural or physiological) through 25 different paradigms, per-
formed in our laboratory over the past 7 years, in chronological order. The
methodological details of our studies are summarised in Table 1, and a full
description of the studies, including each behavioural task, is provided in
the Supporting information (Appendix S1). In each study, the tasks were
conducted in a fixed order determined by the importance we attributed to
each paradigm: the most important target variable was tested in the first
task to eliminate the potential of spillover effects from other tasks (the use
of more than one task is common practice because of the imperative to
maximise the knowledge gained from each subject undergoing pharmaco-
logical treatment). All studies met the guidelines for ethical conduct of
research and were conducted in accordance with the Declaration of Helsinki.
The Biomedical ethics committee of the Universite catholique de Louvain
approved the protocols. Exclusion criteria included medical or psychiatric
condition, substance dependence and female sex (except for the Study 8 on
jealousy, which involved couples and focused on female reactions). The
number of subjects varied between 12 and 95 (based on the standard found
in IN-OT literature) (Table 1, column 4). All studies followed a between-sub-
ject design (except for Study 3 on sleep) and were either single- or double-
blind (see Table 1, column 7). The dose of IN-OT [Syntocinon spray (Sandoz
Pharmaceuticals Corporation East Hanover, NJ, USA); between 24 and 40 IU
to achieve the dosing spectrum found in IN-OT literature] and the provider
varied across studies (see Table 1, column 6). The placebo was always a sal-
ine solution administered in a bottle similar to IN-OT one. Each spray bottle
was numbered and covered with sticky paper that covered the product label.
The timing of the tasks was set according to the current norms in beha-
vioural IN-OT research. Thus, the first task took place at the earliest approxi-
mately 35 min after IN-OT administration (usually 45 min) and, when there
were several tasks in the same study, the last task ended no later than
85 min after IN-OT administration (see Table 1, columns 3 and 8). Generally,
the subjects performed the experiment alone unless the presence of a con-
federate was required (Table 1, column 9). Across all studies, there were no
differences between the treatment groups [OT versus placebo (PL)] with
respect to all baseline measures (all P > 0.05) that were focused on self-
reported questionnaires regarding the dependent variables relevant to each
study (as specified for each study in the Supporting information,
Appendix S1). All studies also involved a personality questionnaire and col-
lected demographic information.
Results
The last two columns of Table 1 summarise the main and interac-
tion effects of IN-OT treatment on target behaviours. We found a
statistically significant main IN-OT effect for only one of 25 tasks,
and a significant interaction effect including the treatment
condition (OT versus PL) for only five out of 25 tasks across our
eight studies and 13 dependent variables (full results and statistical
details are provided in the Supporting information, Appendix S1).
Table 1 (column 10) reports the effect sizes for each variable. Only
13 out of 25 task points estimating effect size reach the lower
bound on a small effect size (Cohen’s d > 0.2). Among those, one
task reaches the lower bound of a moderate effect size (Cohen’s
d > 0.5); another reaches the lower bound of a large effect size
(Cohen’s d > 0.8), although this result has to be interpreted care-
fully because we have failed to replicate it twice (27). Furthermore,
only one task rules out the zero effect size with a 95% confidence
interval (CI) but, once again, the results of this particular study did
not replicate well (27).
To determine the extent of the influence of IN-OT on human
behaviour in our studies, we meta-analysed [i.e. we computed the
cumulative effect sizes using the ‘Comprehensive Meta-Analysis’
software (36)] the effects of IN-OT on cognitive, emotional or beha-
vioural variables (excluding studies of the effects of OT on physio-
logical processes, namely sleep and pain). The aggregated effect
size was not reliably different from zero (Cohen’s d = 0.003; 95%
CI = 0.10 to 0.10). We further aggregated the effects of IN-OT on
variables assessing behaviours, affect or cognition in isolation
(Table 2) and could not reliably reject the null hypothesis for either
(dbehaviours = 0.09; 95% CI = 0.07 to 0.25; daffects = 0.003; 95%
CI = 0.20 to 0.24; dcognitions = 0.1; 95% CI = 0.32 to 0.13).
Finally, aggregating our effect sizes with respect to the three major
behavioural OT theories [i.e. OT as a hormone of affiliation (16); OT
as a hormone of social salience (15); and OT as a hormone of social
approach (17)] (Table 2) did not yield any effects that were reliably
different from zero (dprosocial = 0.04; 95% CI = 0.13 to 0.06;
dsocial saliance = 0.01; 95% CI = 0.11 to 0.10; dsocial approach =
0.002; 95% CI = 0.11 to 0.11).
Discussion
We have reviewed eight studies testing the influence of IN-OT on
human cognition and behaviour, assessing 13 dependent variables
through 25 different paradigms performed in our laboratory since
2009. We found a statistically significant main effect of IN-OT for
only one out of 25 tasks and a significant interaction effect includ-
ing the treatment condition (OT versus PL) for only five out of 25
tasks. All of our hypotheses were derived from the three major
behavioural IN-OT theories [i.e. OT as a hormone of affiliation (16);
OT as a hormone of social salience (15); and OT as a hormone of
social approach (17)].
This large proportion of ‘unexpected’ null findings (92% for the
main effect of IN-OT) raises concerns about the validity of what
we know about the influence of IN-OT on human behaviours and
cognition. As reported in the meta-analytic section, the
aggregated effects are not reliably different from zero, regardless
of how they have been pooled (by dependent variables, by theo-
ries or altogether). Our initial enthusiasm for the IN-OT findings
has slowly faded away over the years and the studies have
turned us from ‘believers’ into ‘skeptics’. This led us to raise sev-
eral questions.
If the published literature on the behavioural IN-OT effects does
not reflect the true state of the world, how has the vast beha-
vioural IN-OT literature accumulated? We reiterate here two possi-
ble accounts. First, the significant findings might be a consequence
of a type I error (the commonly accepted P-value to reach signifi-
cance level allows a false positive rate of 5%). If this is the case,
much unpublished data must remain buried in the drawers of labo-
ratories studying IN-OT.
Second, the significant effect of IN-OT may be the result of
methodological, measurement or statistical artefacts. Because this
© 2016 British Society for NeuroendocrinologyJournal of Neuroendocrinology, 2016, 28, 10.1111/jne.12384
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has been demonstrated for peripheral OT measurements (29), it
should not be excluded here, although the artifacts would be differ-
ent. We recognise four potential sources of generating artefacts in
IN-OT research: (i) small sample between subject-designs that might
not be internally valid; (ii) single-blind studies; (iii) IN-OT pharma-
cokinetics and dosage; and (iv) statistical methods.
The massive use of between-subject designs of relatively small
samples (approximately 30 participants per cell) carries the risk of
attributing effects to IN-OT that are in fact generated by baseline
group differences in various unobservable factors (e.g. personality)
(note that within-subject designs also suffer from limitations such
as reduced statistical power;1.
The use of single-blind studies, where the subject is blind to the
treatment condition but the experimenter is not, introduces the risk
that the experimenter might unconsciously influence the subjects (37).
The dosage of IN-OT and the typical timing of tasks following
IN-OT administration is based on three assumptions that, to our
knowledge, have not been reliably (i.e. through several replications)
confirmed: (i) IN-OT crosses the blood–brain barrier following
administration; (ii) 24–40 IU is a sufficient dose to produce beha-
vioural changes; and (iii) IN-OT pharmacokinetics mimics that of
vasopressin (24).
Recent findings have demonstrated that IN-OT increases OT con-
centration in CSF in both humans (25) and animals (38,39). Further-
more, it has recently been demonstrated that IN-OT modulates
amygdala responses in primates in a manner equivalent to humans
(40). Taken together, such results suggest that IN-OT reaches, directly
or indirectly (41), the central nervous system and this would produce
observable affective, behavioural or cognitive modifications. However,
if IN-OT produces a significant elevation of OT concentration in the
CSF after 30 min in animals, this significant elevation takes place
75 min after IN-OT in humans, which is not consistent with the liter-
ature, where most tasks start 40–45 min after IN-OT. Furthermore, in
a recent study, Quintana et al. (42) suggest that the IN-OT doses
commonly used (24–40 IU) may not be the most adequate. Their
results show that the effect of IN-OT on emotional recognition
appears with an administration of 8 IU but not with 24 IU. Facing
these challenges, further studies are needed to strengthen our knowl-
edge about IN-OT pharmacokinetic properties. Even if IN-OT reaches
the brain, we cannot be sure whether the three assumptions on
which the IN-OT literature is based are valid.
Finally, the use of too small samples (21) and the vast amount
of candidate factors that could potentially moderate the beha-
vioural effects of IN-OT (19,20) might inflate the false discovery
rate unless direct replication efforts and correction for multiple
hypotheses are applied.
Two alternative hypotheses can also explain the apparently puz-
zling results described in the present study.
Table 2. Computed Effect Sizes for Main Variables and Theories.
Cohen’s d
95% Confidence
interval
Size of the effect
according to Cohen’s
norms
Variable
Trust (in Studies 1, 6 and 7) 0.04 0.22 to 0.30 Null effect size
Compassion (in Studies 2 and 7) 0.05 0.21 to 0.14 Null effect size
Empathy (in Study 2) 0.12 0.42 to 0.18 Null to small negative
effect size
Conformism (in Study 5) 0.003 0.36 to 0.36 Null effect size
Jealousy (in Study 8) 0.12 0.39 to 0.14 Null to small negative
effect size
Affects: feeling of sympathy (Study 2), feeling of compassion
(Studies 2 and 7), feeling of guilt (Study 5) and mimetic
desire (Study 6)
With jealousy = 0.02* 0.19 to 0.14 Null effect size
Without jealousy = 0.003 0.20 to 0.24
Behaviours: trust (Studies 1, 6 and 7), compassion (Study 7),
guilt (Study 5) and antisocial conformism (Study 5)
With jealousy = 0.06 0.10 to 0.22 Null effect size
Without jealousy = 0.09 0.07 to 0.25
Cognition: RMEt (Study 2), conformism (Study 5) and visual
perspective taking (Study 6)
0.10 0.32 to 0.13 Null to small negative
effect size
Theory
Prosocial theory [all variables excepted antisocial conformism
(Study 5)[
0.04 0.13 to 0.06 Null effect size
Social salience theory [all variables excepted social sharing of
the emotions (Study 1)]
0.01 0.11 to 0.10 Null effect size
Social approach theory [all variables excepted RMEt (Study 2)
and visual perspective taking (Study 6)]
0.002 0.11 to 0.11 Null effect size
*Because OT could either promotes or decreases jealousy regarding the adopted theoretical approach, we considered it important to report both results.
1for example, see Uri Simonsohn’s post http://datacolada.org/2015/06/22/39-
power-naps-when-do-within-subject-comparisons-help-vs-hurt-yes-hurt-power)
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First, our studies, similar to most published studies on IN-OT,
might be underpowered (21). Thus, the fact that the effects of IN-
OT observed in our studies are nonsignificant does not mean that
they are point estimates of a zero effect. For example, some of our
studies do not rule out a small effect size (Cohen’s d = 0.2) [we
have excluded the highest effect size found in Study 1 (non-mone-
tary trust assessment) because it has been questioned by Lane
et al. (27)]. To detect such effects, or even a moderate effect, a
sample size of between 120 (Study 9: jealousy assessment through
the word completion task, Cohen’s d = 0.518) and 468 (Study 2:
empathy assessment through the RMEt (Read the Mind in th Eyes
test), Cohen’s d = 0.260) participants would be required to detect
an IN-OT effect with 80% power. Such sample sizes are much
greater than the norm in the IN-OT field. Therefore, several of our
findings could potentially have turned significant in well-powered
experiments. Yet, as shown in Table 1, their significance would
might not always be in the expected direction.
A second proposition is that IN-OT effects do exist, although they
are strongly moderated by various factors, making them appear large
under some circumstances but not in others. Through the literature,
more and more findings suggest that IN-OT influences behaviours by
interacting with several moderators (19). Arguably, our findings do
not rule out the possibility that the effects of IN-OT are moderated
by various factors, which is a proposition that is difficult to rule out,
given the infinitely large set of factors that could potentially moder-
ate the behavioural influences of IN-OT (e.g. genes, personality or
environmental factors). Unfortunately, as far as we know, candidate
moderators do not appear to replicate from one study to another
[e.g. in their failed replication of the influence of IN-OT on the RMEt,
Radke and de Bruijn (28) did not find any moderating effect of the
difficulty of an item as demonstrated by Domes et al. (7)] and appear
most often to represent post-hoc data fits rather than a priori
hypotheses [we do not make an exception to the rule: (34)]. Indeed, a
‘significant’ interaction can be found in any data set simply by con-
ducting many statistical tests, even in the absence of a true signal in
the data, unless the test level a is corrected for multiple hypothesis
testing (43,44).
We can either believe that these interactions are statistical arte-
facts (see above) or consider them to be real. If we believe that
they are real, it means that there is no such ‘general effect of IN-
OT on behaviour’ but that the effects of IN-OT are always context-
dependent (19). In the studies reported within the present paper,
relevant potential moderators have been taken into account and
only provided five interaction effects. It is possible that less obvious
moderators, or moderators that we did not measure, would have
provided more significant effects.
At present, we still do not know which of the four hypotheses is
true; IN-OT might not influence human behaviours at all or may
influence it only under specific circumstances. In any case, falsifi-
able theories must emerge to enable progress in our understanding
of the behavioural influences of IN-OT because no current theory
appears to yield robust behavioural predictions, and almost every
behavioural effect can be explained by one of the theories after the
fact. Along this line, although the value of replications cannot be
over-estimated for increasing the reliability of scientific findings
(26,45), replication attempts are almost absent in IN-OT research,
and the only attempts made to replicate high profile publications
did not yield the expected effects [e.g.: trust game investment (46);
non-monetary trust (27); empathy through the RMEt (28)].
In our view, nothing can be taken for granted with IN-OT and
some nonreplicable findings might have biased the development of
existing theories. Hopefully, incorporating null findings and failed
replications into the theoretical process will allow lines to be drawn
between robust, replicable IN-OT effects and facilitate the develop-
ment of falsifiable theories. It is therefore crucial that nonsignifi-
cant findings and failed replications are published (http://
psychfiledrawer.org). Every piece of evidence, even for those experi-
ments that did not yield ‘significant’ effects, should be taken into
account and weighted according to its evidential value.
In the present case, only five articles (2,8,27,34,35) have been
published across the 13 dependent variables that we have assessed,
producing a publication rate of 38.5%. If our laboratory is a repre-
sentative sample of IN-OT research, then, for 626 search results
found in Scopus (http://www.scopus.com) by entering ‘oxytocin’ and
‘human’ as research keys (and limiting the outputs to ‘Psychology’),
approximately 1000 potential studies have remained buried in labo-
ratory drawers. Unravelling these 1000 data sets is extremely
important for understanding whether IN-OT exerts reliable effects
on humans and, if so, under which circumstances.
We believe that a systematic shift in the IN-OT publication pro-
cess is essential for revealing the true state of the world. Pre-regis-
tration of ex-ante hypotheses, replication attempts of the findings
before their submission, and the submission of null results and
failed replications for publication, especially when the studies are
well-powered to detect the original findings, should be encouraged.
Review processes should insist on fully reporting all of the of the
candidate moderators that were measured and tested and encour-
age publication of well-conducted studies, regardless of their
results (47). Many laboratories do report their work transparently.
However, because the editorial and review process does not suffi-
ciently promote nonsignificant results and failed replications, it is
difficult to obtain a complete overview of the IN-OT research field.
One way of improving the standards is by institutionalisation [as is
encouraged by, notably, the American Psychological Association
(http://www.apa.org/research/responsible/publication/index.aspx), the
Association for Psychological Science (http://www.psychological
science.org/index.php/news/releases/psychological-science-sets-new-
standards-for-research-reporting.html) and the NIH (http://
grants.nih.gov/grants/policy/data_sharing/data_sharing_faqs.htm#900)],
as suggested by Leng and Ludwig (24): journals could oblige
researchers to preregister trials, declare hypotheses and primary
outcomes in advance, specify statistical methods to be applied and
fully disclose the data, including those tasks that did not yield
results and assessed moderators that did not moderate the findings.
This would help to drastically decrease reporting bias (i.e. picking
significant results from a battery of tests and only reporting these).
Moreover, researchers could easily test the robustness of their find-
ings by adjusting the a level to the number of tests that were per-
formed (e.g. if the subjects were asked to perform three tasks, the
level of significance would be 0.05/3 = 0.016, instead of 0.05).
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These considerations must be taken into account if we want to
encourage a solid theoretical background for interpreting and
understanding the complex effects of IN-OT and justify all of the
efforts and resources invested in IN-OT research.
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